Role of podocytes in lupus nephritis

Nephrology Dialysis Transplantation

Volumn 24, Issue 12, 2009, Pages 3607-3612

  Trivedi, Sapna ^a   Zeier, Martin ^b   Reiser, Jochen ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Cathepsin L; Lupus nephritis; Motility; Podocytes; Proteinuria

Indexed keywords

ANTIBODY;

CELL DAMAGE; CELL MOTILITY; DISEASE CLASSIFICATION; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; LUPUS ERYTHEMATOSUS NEPHRITIS; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; REVIEW;

HUMANS; LUPUS NEPHRITIS; PODOCYTES;

EID: 71049132313     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp427     Document Type: Review

References (56)

1. Weening JJ, D'Agati VD, Schwartz MM et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004; 15: 241-250
2. Cameron JS. Lupus nephritis. J Am Soc Nephrol 1999; 10: 413-424
3. Kraft SW, Schwartz MM, Korbet SM et al. Glomerular podocytopathy in patients with systemic lupus erythematosus. J Am Soc Nephrol 2005; 16: 175-179
4. Kreidberg JA, Donovan MJ, Goldstein SL et al. Alpha 3beta1 integrin has a crucial role in kidney and lung organogenesis. Development 1996; 122: 3537-3547
5. Kerjaschki D, Ojha PP, Susani M et al. A beta 1-integrin receptor for fibronectin in human kidney glomeruli. Am J Pathol 1989; 134: 481-489
6. Wei C, Moller CC, Altintas MM et al. Modification of kidney barrier function by the urokinase receptor. Nat Med 2008; 14: 55-63
7. Borza CM, Borza DB, Pedchenko V et al. Human podocytes adhere to the KRGDS motif of the alpha3alpha4alpha5 collagen IV network. J Am Soc Nephrol 2008; 19: 677-684
8. Regele HM, Fillipovic E, Langer B et al. Glomerular expression of dystroglycans is reduced in minimal change nephrosis but not in focal segmental glomerulosclerosis. J Am Soc Nephrol 2000; 11: 403-412
9. Faul C, Asanuma K, Yanagida-Asanuma E et al. Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol 2007; 17: 428-437
10. Tryggvason K, Patrakka J, Wartiovaara J. Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med 2006; 354: 1387-1401
11. Mundel P et al. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 1997; 236: 248-258
12. Sever S, Altintas MM, Nankoe SR et al. Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease. J Clin Invest 2007; 117: 2095-2104
13. Reiser J, Oh J, Shirato I et al. Podocyte migration during nephrotic syndrome requires a coordinated interplay between cathepsin L and alpha3 integrin. J Biol Chem 2004; 279: 34827-34832
14. Deji N, Sugimoto T, Kanasaki M et al. Emerging minimal-change nephrotic syndrome in a patient with chronic mesangial proliferative lupus nephritis. Intern Med 2007; 46: 991-995
15. Stankeviciute N, Jao W, Bakir A et al. Mesangial lupus nephritis with associated nephrotic syndrome.J Am Soc Nephrol 1997; 8: 1199-1204
16. Vlahakos D, Foster MH, Ucci AA et al. Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei, and induce glomerular proliferation and proteinuria in vivo. J Am Soc Nephrol 1992; 2: 1345-1354
17. Han TS, Schwartz MM, Lewis EJ. Association of glomerular podocy-topathy and nephrotic proteinuria in mesangial lupus nephritis. Lupus 2006; 15: 71-75
18. Mason LJ, Ravirajan CT, Rahman A et al. Is alpha-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis? Arthritis Rheum 2004; 50: 866-870
19. Atkins RC, Nikolic-Paterson DJ, Song Q et al. Modulators of cres-centic glomerulonephritis. J Am Soc Nephrol 1996; 7: 2271-2278
20. Nitta K, Horita S, Honda K et al. Glomerular expression of cell-cycle-regulatory proteins in human crescentic glomerulonephritis. Virchows Arch 1999; 435: 422-427
21. Thorner PS, Ho M, Eremina V et al. Podocytes contribute to the formation of glomerular crescents. J Am Soc Nephrol 2008; 19: 495-502
22. Moeller MJ, Soofi A, Hartmann I et al. Podocytes populate cellular crescents in a murine model of inflammatory glomerulonephritis. J Am Soc Nephrol 2004; 15: 61-67
23. Bariety J, Bruneval P, Meyrier A et al. Podocyte involvement in human immune crescentic glomerulonephritis. Kidney Int 2005; 68: 1109-1119
24. Ng YY, Fan JM, Mu W et al. Glomerular epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent formation. Nephrol Dial Transplant 1999; 14: 2860-2872
25. Bariety J, Bruneval P, Hill G et al. Posttransplantation relapse of FSGS is characterized by glomerular epithelial cell transdifferentiation. J Am Soc Nephrol 2001; 12: 261-274
26. Perry J, Ho M, Viero S et al. The intermediate filament nestin is highly expressed in normal human podocytes and podocytes in glomerular disease. Pediatr Dev Pathol 2007; 10: 369-382
27. Coers W, Brouwer E, Vos JT et al. Podocyte expression of MHC class I and II and intercellular adhesion molecule-1 (ICAM-1) in experimental pauci-immune crescentic glomerulonephritis. Clin Exp Immunol 1994; 98: 279-286
28. Parry RG, Gillespie KM, Mathieson PW. Effects of type 2 cytokines on glomerular epithelial cells. Exp Nephrol 2001; 9: 275-283
29. Couzi L, Merville P, Deminiere C et al. Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis. Arthritis Rheum 2007; 56: 2362-2370
30. Heymann F, Meyer-Schwesinger C, Hamilton-Williams EE et al. Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury. J Clin Invest 2009; 119: 1286-1297
31. Liu Y, Wu J, Wu H et al. UCH-L1 expression of podocytes in diseased glomeruli and in vitro. J Pathol 2009; 217: 642-653
32. Reiser J, von Gersdorff G, Loos M et al. Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 2004; 113: 1390-1397
33. Garin EH, Diaz LN, Mu W et al. Urinary CD80 excretion increases in idiopathic minimal-change disease. J Am Soc Nephrol 2009; 20: 260-266
34. Zhu J, Sun N, Aoudjit L et al. Nephrin mediates actin reorganization via phosphoinositide 3-kinase in podocytes. Kidney Int 2008; 73: 556-566
35. Benzing T. Signaling at the slit diaphragm. J Am Soc Nephrol 2004; 15: 1382-1391
36. Jones N, Blasutig IM, Eremina V et al. Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes. Nature 2006; 440: 818-823
37. Verma R, Kovari I, Soofi A et al. Nephrin ectodomain engagement results in Src kinase activation, nephrin phosphorylation, Nck recruitment, and actin polymerization. J Clin Invest 2006; 116: 1346-1359
38. Cunard R, Kelly CJ. T cells and minimal change disease. J Am Soc Nephrol 2002; 13: 1409-1411
39. Banas MC, Banas B, Hudkins KL et al. TLR4 links podocytes with the innate immune system to mediate glomerular injury. J Am Soc Nephrol 2008; 19: 704-713
40. Aramburu J, Heitman J, Crabtree GR. Calcineurin: a central controller of signalling in eukaryotes. EMBO Rep 2004; 5: 343-348
41. Crabtree GR, Olson EN. NFAT signaling: choreographing the social lives of cells. Cell 2002; 109(Suppl): S67-S79
42. Meyrier A. Treatment of focal segmental glomerulosclerosis. Expert Opin Pharmacother 2005; 6: 1539-1549
43. Charbit M, Gubler MC, Dechaux M et al. Cyclosporin therapy in patients with Alport syndrome. Pediatr Nephrol 2006
44. Chen D, Jefferson B, Harvey SJ et al. Cyclosporine a slows the progressive renal disease of Alport syndrome (X-linked hereditary nephritis): results from a canine model. J Am Soc Nephrol 2003; 14: 690-698
45. Asanuma K, Kim K, Oh J et al. Synaptopodin regulates the actin-bundling activity of alpha-actinin in an isoform-specific manner. J Clin Invest 2005; 115: 1188-1198
46. Asanuma K, Yanagida-Asanuma E, Faul C et al. Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling. Nat Cell Biol 2006; 8: 485-491
47. Seiler MW, Venkatachalam MA, Cotran RS. Glomerular epithelium: structural alterations induced by polycations. Science 1975; 189: 390-393
48. Seiler MW, Rennke HG, Venkatachalam MA et al. Pathogenesis of polycation-induced alterations ('fusion') of glomerular epithelium. Lab Invest 1977; 36: 48-61
49. Takeda T, McQuistan T, Orlando RA et al. Loss of glomerular foot processes is associated with uncoupling of podocalyxin from the actin cytoskeleton. J Clin Invest 2001; 108: 289-301
50. Schmieder S, Nagai M, Orlando RA et al. Podocalyxin activates RhoA and induces actin reorganization through NHERF1 and Ezrin in MDCK cells. J Am Soc Nephrol 2004; 15: 2289-2298
51. Kerjaschki D. Polycation-induced dislocation of slit diaphragms and formation of cell junctions in rat kidney glomeruli. The effects of low temperature, divalent cations, colchicine, and cytochalasin B. Lab Invest 1978; 39: 430-440
52. Duning K, Schurek EM, Schluter M et al. KIBRA modulates directional migration of podocytes.J Am Soc Nephrol 2008; 19: 1891-1903
53. Kawaguchi M, Hosotani R, Ohishi S et al. A novel synthetic Arg-Gly-Asp-containing peptide cyclo(-RGDf = = V-) is the potent inhibitor of angiogenesis. Biochem Biophys Res Commun 2001; 288: 711-717
54. Faul C, Donnelly M, Merscher-Gomez S et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 2008; 14: 931-938
55. Dube GK, Markowitz GS, Radhakrishnan J et al. Minimal change disease in systemic lupus erythematosus. Clin Nephrol 2002; 57: 120-126
56. Le Hir M, Keller C, Eschmann V et al. Podocyte bridges between the tuft and Bowman's capsule: an early event in experimental crescentic glomerulonephritis. J Am Soc Nephrol 2001; 12: 2060-2071